Executive Summary Selective Estrogen Receptor Degraders (SERD) Therapeutics Market: Share, Size & Strategic Insights CAGR Value The global Selective Estrogen Receptor Degraders (SERD) therapeutics market size was valued at USD 4.80 billion in 2025 and is expected to reach USD 16.46 billion by 2033, at a CAGR of 16.66% during the forecast period The...

Fibroblast Factor Receptor 4 Market – Advancing Targeted Cancer Therapies The Fibroblast Factor Receptor 4 Market is rapidly emerging as a significant segment within oncology research and therapeutic development. Fibroblast growth factor receptors (FGFRs) play key roles in cell growth, survival, and differentiation. Among the FGFR family, FGFR4 has gained particular attention because of...

As per Market Research Future, the Polymer Electrolyte Membrane PEM Fuel Cells Market Share is shaped by technological innovation, regional adoption patterns, and expanding application areas. PEM fuel cells hold a significant share within the broader fuel cell market due to their versatility and performance advantages. The transportation sector accounts for a major portion of market...

Precision Business Insights has published a report on the global stem cells market, estimating its value at USD 20.2 billion in 2025 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% over the forecast period 2026-2032. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these...

"Market Trends Shaping Executive Summary Chimeric Antigen Receptor (CAR)-T Therapy Treatment Market Size and Share CAGR Value The global chimeric antigen receptor (CAR)-T cell therapy market size was valued at USD 2.44 billion in 2023 and is projected to reach USD 5.97 billion by 2031, at a CAGR of 15.3% during the forecast period. Chimeric Antigen Receptor (CAR)-T Therapy...

Global awareness campaigns related to digestive health are encouraging early diagnosis and treatment of ulcers. Healthcare organizations are educating people about symptoms and preventive measures. This awareness is helping expand the market for antiulcer medications. The Antiulcerant Drugs Market is projected to reach US$ 51.01 billion by 2031, growing at a CAGR of 4.4% during...

The global CAR T-cell therapy market size was estimated at USD 5.82 billion in 2025 and is projected to reach USD 22.36 billion by 2033, expanding at a CAGR of 18.06% from 2026 to 2033. Market expansion is primarily supported by the growing global cancer burden, increasing adoption of personalized and cell-based immunotherapies, advancements in gene-editing technologies, and favorable...

The growing demand for personalized medicine is another important factor driving the CAR-T cell therapy market. CAR-T therapy is designed specifically for individual patients, making it a highly targeted treatment option. This personalized approach is improving treatment outcomes for many cancer patients. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 with 17.5% CAGR The global...

Noninvasive cancer diagnostics comprises innovative screening and testing methods that identify cancer related abnormalities through simple sample collection and advanced analytical technologies. By reducing the need for surgical biopsies, these solutions enhance safety and allow for repeated monitoring during treatment. Rapid progress in genomics, proteomics, and artificial intelligence is...